Related Experiment Video

Updated: Jun 22, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Challenges and progress in the development of a serogroup B meningococcal vaccine

Susan Lewis1, Manish Sadarangani, J Claire Hoe

  • 1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford, OX3 7LJ, UK. susan.lewis@paediatrics.ox.ac.uk

Expert Review of Vaccines
|June 3, 2009
PubMed

Insights

Developing effective vaccines against serogroup B meningococci, a leading cause of disease in developed nations, remains challenging due to poor polysaccharide immunogenicity. This review covers outer membrane vesicle and recombinant outer membrane protein vaccine advancements.

Area of Science:

  • Microbiology
  • Vaccinology
  • Immunology

Background:

  • Serogroup B meningococci are a significant cause of meningococcal disease in developed countries.
  • The poor immunogenicity of the capsular polysaccharide hinders effective vaccine development.
  • Outer membrane vesicle vaccines have shown success in clonal outbreaks.

Purpose of the Study:

  • To review recent developments in outer membrane vesicle vaccines.
  • To discuss progress in evaluating recombinant outer membrane protein vaccines.
  • To highlight ongoing research towards a universal serogroup B vaccine.

Main Methods:

  • Review of recent scientific literature on meningococcal vaccines.
  • Analysis of data regarding outer membrane vesicle and recombinant outer membrane protein vaccine efficacy.
  • Discussion of challenges and future directions in vaccine development.

Main Results:

  • Outer membrane vesicle vaccines are effective for specific outbreaks.
  • Recombinant outer membrane protein vaccines show promise for broader protection.
  • Challenges remain in achieving universal coverage against diverse serogroup B strains.

Conclusions:

  • Continued research into novel vaccine platforms is crucial.
  • Outer membrane vesicle and recombinant protein approaches represent key strategies.
  • A universal vaccine for endemic serogroup B meningococcal disease is a critical unmet need.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...